Nutrición clínica y dietética hospitalaria/Nutrición clínica, dietética hospitalaria,
Год журнала:
2024,
Номер
44(3)
Опубликована: Июль 28, 2024
Introduction
and
Methods:
This
observational
retrospective
cohort
study
was
conducted
in
the
ICU
of
Wahidin
Sudirohusodo
Hospital,
Indonesia,
from
April
2022
to
March
2023.
All
patients
admitted
during
period
were
considered.
Data
collected
medical
records
included
patient
demographics,
clinical
characteristics,
prognostic
indicators,
outcomes.
Bivariate
multivariate
regression
analysis
used
evaluate
associations
between
indicators
mortality
both
low-risk
high-risk
subgroup.
The
results
presented
as
hazard
ratios
(HRs)
with
95%
confidence
intervals
(CIs).
To
predict
accuracy
biomarker,
Receiver
Operating
Characteristic
(ROC)
curve
conducted.
area
under
ROC
(AUC)
calculated
discriminative
ability
each
biomarker
Result:
In
a
1,106
patients.
length
stay
hospital
for
survivors
is
shorter
than
non-survivors.
Hazard
ratio
showed
that
higher
PNI
significantly
reduced
risk
death
(unadjusted
HR
0.914,
adjusted
0.910),
whereas
CAR
NLR
associated
increased
(CAR
unadjusted
1.020,
1.017;
1.018,
1.014
).
effect
less
pronounced
at
high
nutritional
risk,
nonsignificant
values.
CRP/Albumin
(AUC:
0.696),
0.575),
0.325).
Conclusion:
NLR,
PNI,
are
valuable
settings,
providing
crucial
information
on
especially
low
risk.
data
supports
their
use
assessments
tailor
interventions
address
inflammation
deficits
BMJ,
Год журнала:
2025,
Номер
unknown, С. e082583 - e082583
Опубликована: Янв. 15, 2025
Abstract
Objective
To
evaluate
whether
the
immunomodulatory
drug
thymosin
α1
reduces
mortality
in
adults
with
sepsis.
Design
Multicentre,
double
blinded,
placebo
controlled
phase
3
trial.
Setting
22
centres
China,
September
2016
to
December
2020.
Participants
1106
aged
18-85
years
a
diagnosis
of
sepsis
according
sepsis-3
criteria
and
randomly
assigned
1:1
ratio
receive
(n=552)
or
(n=554).
A
stratified
block
method
was
used
for
randomisation,
participants
were
by
age
(<60
≥60
years)
centre.
Interventions
Subcutaneous
injection
every
12
hours
seven
days
unless
discontinued
owing
discharge
from
intensive
care
unit,
death,
withdrawal
consent.
Main
outcome
measure
The
primary
28
day
all
cause
after
randomisation.
All
analyses
based
on
modified
intention-to-treat
set,
including
who
received
at
least
one
dose
study
drug.
Results
Of
enrolled
study,
1089
included
(thymosin
group
n=542,
n=547).
occurred
127
(23.4%)
132
(24.1%)
(hazard
0.99,
95%
confidence
interval
0.77
1.27;
P=0.93
log-rank
test).
No
secondary
safety
differed
statistically
significantly
between
two
groups.
prespecified
subgroup
analysis
showed
potential
differential
effect
years:
hazard
1.67,
1.04
2.67;
0.81,
0.61
1.09;
P
interaction=0.01)
diabetes
(diabetes:
0.58,
0.35
0.99;
no
diabetes:
1.16,
0.87
1.53;
interaction=0.04).
Conclusions
This
trial
found
clear
evidence
suggest
that
decreases
Trial
registration
ClinicalTrials.gov
NCT02867267
.
Frontiers in Immunology,
Год журнала:
2024,
Номер
14
Опубликована: Янв. 25, 2024
Introduction
Early
diagnosis
of
sepsis
and
discrimination
from
SIRS
is
crucial
for
clinicians
to
provide
appropriate
care,
management
treatment
critically
ill
patients.
We
describe
identification
mRNA
biomarkers
peripheral
blood
leukocytes,
able
identify
severe,
systemic
inflammation
(irrespective
origin)
differentiate
Sepsis
SIRS,
in
adult
patients
within
a
multi-center
clinical
study.
Methods
Participants
were
recruited
Intensive
Care
Units
(ICUs)
multiple
UK
hospitals,
including
fifty-nine
with
abdominal
sepsis,
eighty-four
pulmonary
forty-two
Out-of-Hospital
Cardiac
Arrest
(OOHCA),
sampled
at
four
time
points,
addition
thirty
healthy
control
donors.
Multiple
parameters
measured,
SOFA
score,
many
differences
observed
between
groups.
Differential
gene
expression
analyses
performed
using
microarray
hybridization
data
analyzed
combination
parametric
non-parametric
statistical
tools.
Results
Nineteen
high-performance,
differentially
expressed
identified
combined
SIRS/Sepsis
groups
(FC>20.0,
p<0.05),
termed
‘indicators
inflammation’
(I°I),
CD177,
FAM20A
OLAH.
Best-performing
minimal
signatures
e.g.
FAM20A/OLAH
showed
good
accuracy
determination
(AUC>0.99).
Twenty
entities,
‘SIRS
or
Sepsis’
(S°S)
biomarkers,
(FC>2·0,
p-value<0.05).
Discussion
The
best
performing
signature
discriminating
was
CMTM5/CETP/PLA2G7/MIA/MPP3
(AUC=0.9758).
I°I
S°S
variably
other
independent
datasets,
this
may
be
due
technical
variation
the
study/assay
platform.
Journal of Inflammation Research,
Год журнала:
2025,
Номер
Volume 18, С. 2091 - 2103
Опубликована: Фев. 1, 2025
Purpose:
Current
prognostic
scoring
systems
for
newly
diagnosed
primary
central
nervous
system
lymphoma
(PCNSL),
such
as
IELSG
score
and
MSKCC
score,
are
widely
used
but
have
limitations
in
clinical
practice.
This
study
aimed
to
develop
a
novel
model
based
on
real
data
compare
it
with
existing
systems.
Patients
Methods:
A
total
of
288
patients
PCNSL
were
recruited.
randomly
allocated
the
development
validation
cohorts.
The
least
absolute
shrinkage
selection
operator
(LASSO)
regression
multivariate
Cox
analysis
identify
risk
factors
overall
survival
(OS)
construct
nomogram.
Additionally,
Kaplan-Meier
curves
plotted
show
stratification
ability
groups.
Results:
Eastern
Cooperative
Oncology
Group
performance
status
(ECOG-PS),
albumin,
two
inflammatory
biomarkers
D-Dimer,
neutrophil-to-lymphocyte
ratio
(NLR)—were
independent
predictors
inferior
OS.
demonstrated
concordance
Index
(C-index)
0.731
0.679
cohorts,
respectively.
In
terms
time
dependent
area
under
curve
(AUC)
values
OS,
cohort
exhibited
0.765,
0.762,
0.812
1-year,
3-year,
5-year
corresponding
AUC
0.711,
0.731,
0.840,
calibration
showed
excellent
concordance.
also
provided
superior
compared
Conclusion:
presents
predicting
OS
PCNSL.
accurately
effectively
stratifies
prognosis
offers
valuable
guidance
decision
making.
Keywords:
PCNSL,
model,
stratification,
NLR,
D-Dimer
Health Science Reports,
Год журнала:
2025,
Номер
8(3)
Опубликована: Март 1, 2025
Novel
biomarkers,
such
as
neutrophil
lymphocyte
ratio,
monocyte
to
platelet
derived
systemic
immune-inflammation
index,
inflammation
response
and
aggregate
index
of
inflammation,
have
shown
promising
prognostic
value,
especially
in
ICU
settings.
We
aimed
evaluate
the
potential
mentioned
factors
mortality
predictors
a
heterogeneous
cohort.
conducted
retrospective
cohort
study
using
data
obtained
from
intensive
care
unit
(ICU)
records
311
patients.
evaluated
strength
inflammatory
parameters
upon
admission,
48
h
later,
their
dynamic
changes
within
this
period
predicting
mortality.
used
multivariate
logistic
regression
with
backward
elimination,
which
were
further
validated
ROC
calibration
curves.
Interaction
terms
added
assess
possible
modifications
predictive
performance
ratios
across
various
subgroups
NLPR,
post
admission
(p
<
0.001,
OR:
7.3436,
95%
CI:
3.2986-17.2619)
NLPR
during
first
=
0.018,
2.3826,
1.2069-6.7112),
significant
models.
The
model,
including
48-h
had
highest
AUC
ROC,
slope,
lowest
AIC
(0.8671,
0.8622,
229.12,
respectively).
Also,
decreases
significantly
among
patients
background
CVA.
level,
post-ICU
its
stay,
predict
critically
ill
These
findings
can
serve
practical
accessible
mortality,
particularly
settings,
where
traditional
scoring
systems
may
not
be
routinely
available.
BMC Cardiovascular Disorders,
Год журнала:
2025,
Номер
25(1)
Опубликована: Март 25, 2025
Predicting
all-cause
readmission
in
patients
with
heart
failure
(HF)
is
crucial.
This
study
investigated
the
independent
risk
factors
for
short-term
and
assessed
potential
mediators
involved
this
process.
We
evaluated
data
from
2,254
HF
admitted
to
our
institution
between
January
2019
December
2020.
Logistic
regression
analysis
was
used
examine
association
sarcopenia
index
(SI),
neutrophil-to-lymphocyte
ratio
(NLR),
hemoglobin-to-red
cell
distribution
width
(HRR),
30-d
readmission.
A
restricted
cubic
spline
model
three
knots
non-linear
relationships
confounders
risk.
mediation
performed
evaluate
direct
indirect
effects,
as
well
proportion
of
mediation.
The
mean
age
participants
72
±
12
years,
1,324
males
(58.7%).
rate
7.1%.
HRR
independently
associated
among
biomarkers,
whereas
SI
NLR
showed
no
significant
correlation.
relationship
found
risk,
an
inflection
point
at
0.94.
Patients
<
0.94
exhibited
a
significantly
higher
readmission,
≥
Mediation
revealed
that
N-terminal
pro-B-type
natriuretic
peptide
(NT-proBNP)
partially
mediated
relationship,
which
accounted
13.6%
effect.
predictor
observed.
An
inverse
0.94,
Additionally,
NT-proBNP
identified
partial
mediator
relationship.
Journal of Clinical Medicine,
Год журнала:
2025,
Номер
14(7), С. 2509 - 2509
Опубликована: Апрель 7, 2025
Background/Objectives:
Identifying
reliable
biomarkers
for
healthy
aging
and
longevity
is
a
fundamental
challenge
in
research
medical
sciences.
The
neutrophil-to-lymphocyte
ratio
(NLR)
readily
measurable
indicator
of
immune
balance
that
reflects
the
interplay
between
innate
activation
adaptive
suppression.
Methods:
This
study
examined
NLR
values
204
physically
residents
(98
men
106
women)
stratified
into
four
lifespan
categories
based
on
death
certificates.
Page's
test
ordinal
regression
(Cumulative
Link
Model)
were
used
to
assess
trends
with
longevity.
Results:
In
men,
downward
trend
was
observed.
women,
significant
age-related
decline
identified,
longer-lived
individuals
showing
notably
lower
compared
their
shorter-lived
counterparts.
findings
suggest
associated
longer
survival,
particularly
older
reflecting
superior
regulation
reduced
systemic
inflammation.
Conversely,
elevated
may
indicate
dysfunction
heightened
inflammatory
burden.
Conclusions:
results
this
complement
existing
findings,
reinforcing
critical
importance
supporting
These
also
underscore
potential
as
robust
biomarker
evaluating
function
anticipating
resilience
decline,
offering
practical
tool
assessing
health
population.
BMC Cardiovascular Disorders,
Год журнала:
2025,
Номер
25(1)
Опубликована: Апрель 11, 2025
This
retrospective
cohort
study
was
designed
to
examine
the
relationship
between
neutrophil-lymphocyte
ratio
(NLR)
and
1-year
risk
of
death
in
patients
with
acute
heart
failure
(AHF)
intensive
care
unit
(ICU).
We
retrospectively
analyzed
1,176
AHF
from
MIMIC-IV
database.
Cox
regression
used
evaluate
NLR
mortality
after
adjusting
for
covariates.
Nonlinear
associations
optimal
cutoff
values
were
determined
using
restricted
cubic
splines.
Propensity
score
matching
eliminate
imbalances
baseline
confounders.
Kaplan-Meier
survival
analysis
further
confirmed
correctness
threshold.
The
ROC
diagnostic
accuracy
long-term
outcomes.
Subgroup
analyses
performed
assess
generality
specific
populations.
rate
lowest
lower
tertile
group
(<
5.43)
highest
upper
(>
13.53,
P
trend
<
0.001).
showed
a
nonlinear
correlation
(P
Non-linearity
=
0.0075),
increasing
significantly
when
exceeded
11.11.
AUC
predicting
0.579
(95%CI
0.542-0.617).
not
different
outcomes
most
groups,
but
association
stronger
who
did
have
sepsis.
Elevated
NLR,
marker
heightened
systemic
inflammation,
associated
higher
ICU
AHF.
Not
applicable.
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(14), С. 4011 - 4011
Опубликована: Июль 9, 2024
:
The
aim
of
the
current
study
is
to
evaluate
effects
inflammation
markers
on
infection
and
mortality
in
patients
over
65
years
age
monitored
intensive
care
unit
(ICU).
In
this
study,
we
attempted
determine
significance
pan-immune-inflammation
value
(PIV);
neutrophil-lymphocyte
ratio
(NLR);
platelet-lymphocyte
(PLR);
monocyte-lymphocyte
(MLR);
systemic
immune-inflammatory
index
(SII);
immune
response
(SIRI);
multi-inflammatory
indices
(MIIs)
1,
2,
3;
CRP/albumin
(a
new
biomarker)
as
prognostic
being
ICU.
Diagnostics,
Год журнала:
2024,
Номер
14(18), С. 2102 - 2102
Опубликована: Сен. 23, 2024
Background/Objectives:
Chronic
heart
failure
(CHF)
is
characterized
by
complex
pathophysiology,
leading
to
increased
hospitalizations
and
mortality.
Inflammatory
biomarkers
such
as
the
neutrophil-to-lymphocyte
ratio
(NLR)
platelet-to-lymphocyte
(PLR)
provide
valuable
diagnostic
insights.
Methods:
This
study
evaluates
prognostic
relationship
between
NLR,
PLR,
and,
in
a
specific
subcohort,
N-terminal
pro
B-type
natriuretic
peptide
(NT-proBNP),
alongside
length
of
stay
(LOS)
90-day
readmission
rates
CHF
patients,
irrespective
phenotype.
A
retrospective
analysis
427
admissions
(males
=
57.84%)
was
conducted.
Results:
The
mean
age
entire
population
68.48
±
11.53
years.
average
LOS
8.33
5.26
days,
with
rate
73
visits
(17.09%)
for
56
patients.
NLR
(3.79
3.32)
showed
low
but
positive
correlation
(r
0.222,
p
<
0.001).
Conversely,
PLR
(144.84
83.08)
did
not
demonstrate
significant
association
LOS.
presented
negative
days
until
next
admission
−0.023,
0.048).
In
prespecified
subanalysis
323
admissions,
NT-proBNP
exhibited
Pearson
0.241,
0.001)
0.151,
0.006).
Conclusions:
impact
across
phenotypes
may
suggest
role
systemic
inflammation
understanding
managing
CHF.